Biobank study using tumor tissue to grow patient tumor models
Part of Cancer clinical trials.
This study takes small samples of your breast tumor tissue after (or during) treatment and grows them in lab animals to better study breast cancer. It may help researchers test future ideas for treating aggressive breast cancer types like triple-negative or Luminal B.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman with breast cancer that is either triple-negative or Luminal B (Luminal B).
- Your cancer type and treatment situation match the study: metastatic triple-negative, certain triple-negative subtypes (including inflammatory or metaplastic), or Luminal B after neoadjuvant chemotherapy, with leftover tumor tissue of a required size.
- You must have enough remaining tumor tissue after treatment (about 15–30 mm depending on the cancer subtype), based on the lab specimen and/or end-of-treatment imaging.
- Your health/function is good enough to join (ECOG score of 0–2, meaning you can do some activities).
- You agree to the study by signing consent and have a social security coverage in the study setting.
- You are not pregnant, and you can participate freely (no legal deprivation of liberty).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study looks at how well early breast cancer shrinks with treatment and how that matches with what doctors find after surgery under the microscope. The goal is to learn better ways to predict and assess treatment success.
This study looks at tumor “clues” by using tissue and blood samples in people with metastatic breast cancer (with specific subtype). It aims to better understand what drives the cancer, which may help guide future treatments.
This trial tests a personalized approach to cancer treatment. Doctors will grow a ‘mini-tumor’ from a biopsy of your cancer in the lab to help find the best therapy for you. It is for people with advanced breast cancer that has not responded well to standard treatments.
This study is testing whether it is safe and practical to take multiple small tissue samples (biopsies) from different sites of your breast cancer over time. The goal is to learn how breast cancer changes as it grows, which could help doctors develop better treatments.
This study collects tumor-related samples from people with invasive breast cancer who are having surgery after treatment before surgery. Researchers use your samples to create lab models (called PDX and organoids) to help study breast cancer and find better future treatments.
This study collects and stores tissue and fluid samples from people with a breast lump or breast cancer so researchers can study cancer biology in the future. It may help future patients by allowing better lab tests and research on why breast cancer starts, grows, and comes back.
Hear when a new Breast Cancer Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.